Screening compounds and inhibitors
VIRTUAL SCREENING OF HETEROCYCLIC COMPOUNDS AGAINST ANGIOTENSIN CONVERTING ENZYME FOR POTENTIAL ANTIHYPERTENSIVE INHIBITORS
6
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds
17
Screening of ferulic acid related compounds as inhibitors of xanthine oxidase and cyclooxygenase-2 with anti-inflammatory activity
6
Structure based virtual screening for identification of novel inhibitors against bace1 from selective medicinal plant compounds
5
Repositioning therapeutics for COVID 19: virtual screening of the potent synthetic and natural compounds as SARS CoV 2 3CLpro inhibitors
21
Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption
11
Screening of new compounds for the management of erectile dysfunction
5
Development of a Screening Assay for Type III Secretion System Inhibitors and High Throughput Screening Campaign of Inhibitors of PRP of Staphylococcus aureus
377
Gene expression based screening for inhibitors of PDGFR signaling
14
Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities
26
IN SILICO SCREENING FOR ALPHA GLUCOSIDASE INHIBITORS OF CHROMONE DERIVATIVES
7
In silico screening strategies for novel inhibitors of parasitic diseases
10
Screening of selective histone deacetylase inhibitors by proteochemometric modeling
10
Identification of mutant p53 inhibitors by high-content screening
99
Yeast-based assays for screening 11β-HSD1 inhibitors
13
Virtual Screening for Novel HIV-Reverse Transcriptase Inhibitors
5
Identification of novel serotonin transporter compounds by virtual screening.
12
Screening of Bioactive Compounds against Nonreceptor Fyn Kinase: Virtual Screening and Network Approach
8
Molecular Docking Studies; Dietary Compounds As HIV 1 Protease Inhibitors
16
Vanadium Compounds as PTP Inhibitors
19